API
LMAT icon

Advisor Partners II’s LeMaitre Vascular LMAT Stock Holding History

Advisor Partners II’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,221
Closed -$217K – 1280
2023
Q2 		$217K Buy
+3,221
New +$196K 0.01% 963

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisor Partners II's LMAT Position: Q3 2023 in Review

Advisor Partners II sold out of LeMaitre Vascular (LMAT) in Q3 2023, closing a stake of 3,221 shares — an estimated $217K sold.

Advisor Partners II first reported a position in LMAT in Q2 2023 and held it in 1 quarter. The position peaked at $217K in Q2 2023. 220 funds tracked by Wall St. Rank hold LMAT as of Q3 2023.

  • Advisor Partners II reported no remaining LeMaitre Vascular position as of Q3 2023 after selling out during the quarter.
  • Advisor Partners II sold 3,221 LeMaitre Vascular shares in Q3 2023, an estimated $217K.
  • Advisor Partners II first reported a position in LeMaitre Vascular in Q2 2023 and held it in 1 quarter.
  • Advisor Partners II's LeMaitre Vascular position peaked at $217K in Q2 2023.
  • 220 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.